European Drug Policy

May 18, 2020

Péter Sárosi

The Effects of COVID-19 on the Hungarian Drug Market

The Hungarian drug market was affected by the COVID-19 crisis but it is far from being disrupted – read an English summary of an online survey conducted by Drugreporter among its Hungarian readers.

May 5, 2020

Péter Sárosi

Boosters – (Not so) New Drugs in Poland

The members of Drugreporter’s video advocacy network produced a movie about the new generation of synthetic drugs that conquered Poland in 2008 – and are still popular.

Apr 7, 2020

Péter Sárosi

Reducing the Harms of a Broken System: Social Justice Demands During COVID-19

In this time of crisis, harm reduction activists must go beyond their regular demands and urge governments to act quickly to prevent a public health crisis transforming into a social collapse (Greek translation).

Apr 1, 2020

Igor Kuzmenko

Road 184

“Road 184” is a movie about the Estonian Community of People who Use Psychotropic Substances, LUNEST, the first officially registered Estonian organization that protects the rights of drug users. Today, LUNEST unites people who speak different languages and have different citizenship, as well as those who do not have any citizenship in Estonia.

Mar 22, 2020

Igor Kuzmenko

The Rising Wave

“The Rising Wave” is a movie about the organization from Lithuania “Young Wave” (“Jauna Banga” in Lithuanian), which deals with the use of psychoactive substances by young people.

Mar 19, 2020

Péter Sárosi

Harm Reduction Must Go On: Position of European Harm Reduction Networks on COVID-19

The Correlation European Harm Reduction Network and the Eurasian Harm Reduction Association published a joint position on the continuity of harm reduction services during the COVID-19 crisis. (PDF: English Russian German Portuguese Spanish Hungarian Polish Czech Montenegrin)

Mar 6, 2020

Péter Sárosi

How to Make a New EU Drugs Strategy?

The EU Drugs Strategy (2013-20) expires this year and there are huge gaps in its implementation. Policy documents that are not enforced damage the credibility of the EU. To avoid this, we should revise the paradigm and create a new framework for actions.

Feb 21, 2020

Péter Sárosi

Cannabis Legalisation Has Arrived in Europe: Civil Society Should Not Be Silent

It is time for drug professionals, including the harm reduction community, to have a say about the upcoming regulation of the European cannabis market. If not, we miss an important historical opportunity to shape the future.

Oct 17, 2019

Péter Sárosi

What Works on the Ground in Europe? – 4 Case Studies

In this report we present four best practices in the field of drug demand and harm reduction from three countries. With this report, we would like to promote the culture of evaluation both among civil society organisations and decision makers.

Jul 11, 2019

Péter Sárosi

“Marseilles Bears a Heavy Stigma of Drug Trafficking and Use” – An Interview with Beatrice Stambul

The city of Marseilles decided to open its first drug consumption room. Read our interview with Beatrice Strambul, who has been in the forefront of the harm reduction movement in France since the 1990s.

MENU

TOPICS

SERIES

MENU

TOPICS

SERIES

European Drug Policy

The Effects of COVID-19 on the Hungarian Drug Market

Boosters – (Not so) New Drugs in Poland

Reducing the Harms of a Broken System: Social Justice Demands During COVID-19

Road 184

The Rising Wave

Harm Reduction Must Go On: Position of European Harm Reduction Networks on COVID-19

How to Make a New EU Drugs Strategy?

Cannabis Legalisation Has Arrived in Europe: Civil Society Should Not Be Silent

What Works on the Ground in Europe? – 4 Case Studies

“Marseilles Bears a Heavy Stigma of Drug Trafficking and Use” – An Interview with Beatrice Stambul

MENU

ADDRESS

OUR WEBSITES

TOPICS

SERIES